Biometric Recognition Based on Recurrence Plot and InceptionV3 Model Using Eye Movements.

The ability to use eye movement signals as a feature in biometric recognition is a novel characteristic of biometric recognition technology. However, present technologies have not fully exploited the correlation features between eye movement signals. To address this, we propose an eye movement biometric recognition model that is based on recurrence plot encoding and the InceptionV3 model. We first encode the original eye movement signal using the recurrence plot to obtain a 2-D image that is then used as input for the InceptionV3 model to perform biometric recognition. Our experimental results using the GazeBaseV2.0 eye movement dataset demonstrate that our proposed model achieved a high biometric recognition accuracy of 96.58% ± 0.66% using the recurrence plot transformation of the horizontal gaze position signals and the InceptionV3 model, surpassing the accuracy achieved by other models. The use of horizontal gaze position eye movement signals for biometric recognition outperforms the use of vertical gaze position signals when using our proposed methods. Furthermore, the biometric recognition that is achieved through recurrent plot encoding is superior to that achieved using Markov transition fields and Gramian angular field transformations.

Air traffic control forgetting prediction based on eye movement information and hybrid neural network.

Control forgetting accounts for most of the current unsafe incidents. In the research field of radar surveillance control, how to avoid control forgetting to ensure the safety of flights is becoming a hot issue which attracts more and more attention. Meanwhile, aviation safety is substantially influenced by the way of eye movement. The exact relation of control forgetting with eye movement, however, still remains puzzling. Motivated by this, a control forgetting prediction method is proposed based on the combination of Convolutional Neural Networks and Long-Short Term Memory (CNN-LSTM). In this model, the eye movement characteristics are classified in terms of whether they are time-related, and then regulatory forgetting can be predicted by virtue of CNN-LSTM. The effectiveness of the method is verified by carrying out simulation experiments of eye movement during flight control. Results show that the prediction accuracy of this method is up to 79.2%, which is substantially higher than that of Binary Logistic Regression, CNN and LSTM (71.3%, 74.6%, and 75.1% respectively). This work tries to explore an innovative way to associate control forgetting with eye movement, so as to guarantee the safety of civil aviation.

The predictive value of total-body PET/CT in non-small cell lung cancer for the PD-L1 high expression.

Purpose: Total-body positron emission tomography/computed tomography (PET/CT) provides faster scanning speed, higher image quality, and lower injected dose. To compensate for the shortcomings of the maximum standard uptake value (SUVmax), we aimed to normalize the values of PET parameters using liver and blood pool SUV (SUR-L and SUR-BP) to predict programmed cell death-ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC) patients. Materials and methods: A total of 138 (104 adenocarcinoma and 34 squamous cell carcinoma) primary diagnosed NSCLC patients who underwent 18F-FDG-PET/CT imaging were analyzed retrospectively. Immunohistochemistry (IHC) analysis was performed for PD-L1 expression on tumor cells and tumor-infiltrating immune cells with 22C3 antibody. Positive PD-L1 expression was defined as tumor cells no less than 50% or tumor-infiltrating immune cells no less than 10%. The relationships between PD-L1 expression and PET parameters (SUVmax, SUR-L, and SUR-BP) and clinical variables were analyzed. Statistical analysis included χ2 test, receiver operating characteristic (ROC), and binary logistic regression. Results: There were 36 patients (26%) expressing PD-L1 positively. Gender, smoking history, Ki-67, and histologic subtype were related factors. SUVmax, SUR-L, and SUR-BP were significantly higher in the positive subset than those in the negative subset. Among them, the area under the curve (AUC) of SUR-L on the ROC curve was the biggest one. In NSCLC patients, the best cutoff value of SUR-L for PD-L1-positive expression was 4.84 (AUC = 0.702, P = 0.000, sensitivity = 83.3%, specificity = 54.9%). Multivariate analysis confirmed that age and SUR-L were correlated factors in adenocarcinoma (ADC) patients. Conclusion: SUVmax, SUR-L, and SUR-BP had utility in predicting PD-L1 high expression, and SUR-L was the most reliable parameter. PET/CT can offer reference to screen patients for first-line atezolizumab therapy.